Dasatinib , CAS No.302962-49-8

CAS: 302962-49-8 Cat. No.: D1371597-GMP Peso molecular: 488.01 Número EC: 801-607-0

Storage

Room temperature

Shipped In

Normal

Descripción general

Dasatinib (BMS-354825) (GMP) is a GMP grade Dasatinib. GMP grade small molecules can be used as auxiliary reagents in cell therapy. Dasatinib (BMS-354825) is an ATP competitive dual Src/Bcr Abl inhibitor with effective anti-tumor activity. The Ki values for Src and Bcr Abl were 16 pM and 30 pM, respectively. Dasatinib inhibited Bcr Abl and Src with IC50 values of less than 1.0 nM and 0.5 nM, respectively. Dasatinib also induced apoptosis and autophagy.

Specifications

Condiciones de almacenamiento de almacenamiento

Room temperature

Enviado en

Normal

Propiedades del producto

• ALogP: 3.6

Nombres e identificadores

• Sonrisas canónicas: CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
• IUPAC Name: N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide
• InChIKey: ZBNZXTGUTAYRHI-UHFFFAOYSA-N
• INCHI: 1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)
• Isómeros SMILES: CC1=C(C(=CC=C1)Cl)NC(=O)C2=CN=C(S2)NC3=CC(=NC(=N3)C)N4CCN(CC4)CCO
• CAS alternativo: 302962-49-8,863127-77-9
• Número NSC: 732517
• Términos de entrada MeSH: (18F)-N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide;354825, BMS;BMS 354825;BMS-354825;BMS354825;dasatinib;N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methyl
• Peso molecular: 488.01
• Reaxy-Rn: 9966762
• Reaxys-RN_link_address: https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=9966762&ln=

Taxonomic Classification

Taxonomy Tree

• Kingdom Organic compounds
  • Superclass Benzenoids
    • Clase Benzene and substituted derivatives
      • Subclass Anilides

• Kingdom: Organic compounds
• Superclass: Benzenoids
• Clase: Benzene and substituted derivatives
• Subclass: Anilides
• Intermediate Tree Nodes: Not available
• Direct Parent: Aromatic anilides
• Alternative Parents: N-arylpiperazines Thiazolecarboxamides 2-heteroaryl carboxamides Dialkylarylamines 2,5-disubstituted thiazoles Toluenes Aminopyrimidines and derivatives Chlorobenzenes N-alkylpiperazines 2-amino-1,3-thiazoles Aryl chlorides Imidolactams Heteroaromatic compounds Trialkylamines Amino acids and derivatives Secondary carboxylic acid amides 1,2-aminoalcohols Azacyclic compounds Secondary amines Hydrocarbon derivatives Organopnictogen compounds Primary alcohols Organochlorides Organic oxides
• Molecular Framework: Aromatic heteromonocyclic compounds
• Substituents: Aromatic anilide - N-arylpiperazine - 2-heteroaryl carboxamide - Thiazolecarboxamide - Thiazolecarboxylic acid or derivatives - Dialkylarylamine - Halobenzene - 2,5-disubstituted 1,3-thiazole - Chlorobenzene - Aminopyrimidine - Toluene - N-alkylpiperazine - 1,4-diazinane - Piperazine - Pyrimidine - Aryl chloride - Aryl halide - 1,3-thiazol-2-amine - Imidolactam - Heteroaromatic compound - Thiazole - Azole - Amino acid or derivatives - Tertiary amine - 1,2-aminoalcohol - Tertiary aliphatic amine - Carboxamide group - Secondary carboxylic acid amide - Alkanolamine - Azacycle - Organoheterocyclic compound - Secondary amine - Carboxylic acid derivative - Amine - Organic nitrogen compound - Alcohol - Organic oxygen compound - Hydrocarbon derivative - Organic oxide - Organopnictogen compound - Primary alcohol - Organooxygen compound - Organonitrogen compound - Organohalogen compound - Organochloride - Aromatic heteromonocyclic compound
• Descripción: This compound belongs to the class of organic compounds known as aromatic anilides. These are aromatic compounds containing an anilide group in which the carboxamide group is substituted with an aromatic group. They have the general structure RNC(=O)R', where R= benzene, and R = aryl group.
• External Descriptors: tertiary amino compound - N-arylpiperazine - N-(2-hydroxyethyl)piperazine - aminopyrimidine - monocarboxylic acid amide - organochlorine compound - 1,3-thiazole - secondary amino compound

Data sources

1. Djoumbou Feunang Y, Eisner R, Knox C, Chepelev L, Hastings J, Owen G, Fahy E, Steinbeck C, Subramanian S, Bolton E, Greiner R, and Wishart DS. ClassyFire: Automated Chemical Classification With A Comprehensive, Computable Taxonomy. Journal of Cheminformatics, 2016, 8:61.

DOI: 10.1186/s13321-016-0174-y

Propiedades químicas y físicas

• Punto de fusión (°C): 280 °C

Referencias

1. Xiaofei Zhang, Mengyuan Lv, Yuyang Wang, Nan Zhang, Di Chen.  (2025)  Inner-wall biochar-coated pipette tip microextraction for rapid and sustainable determination of tyrosine kinase inhibitors in plasma.  RSC Advances,  15  (40): (33536-33548).  [PMID:40959299] [10.1039/D5RA05405B]

2. Zhiming Wang, Jing Tan, Mengxuan Li, Can Gao, Wenwen Li, Jing Xu, Changchuan Guo, Zhenzhen Chen, Rong Cai.  (2023)  Clickable Photoreactive ATP-Affinity Probe for Global Profiling of ATP-Binding Proteins.  ANALYTICAL CHEMISTRY,      [PMID:37993803] [10.1021/acs.analchem.3c02694]

3. Yao Liu, Zhichao He, Heng Liang, Minzhen Han, Jinxingyi Wang, Qian Liu, Yanping Guan.  (2023)  A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma.  ANALYTICAL BIOCHEMISTRY,      [PMID:37429484] [10.1016/j.ab.2023.115230]

4. Lu Yang, Jiaxi Xu, Zheng Xie, Faquan Song, Xin Wang, Rupei Tang.  (2021)  Carrier-free prodrug nanoparticles based on dasatinib and cisplatin for efficient antitumor in vivo.  Asian Journal of Pharmaceutical Sciences,      [PMID:35027952] [10.1016/j.ajps.2021.08.001]

5. Zhao-Yang Wang, Hai-Long Wu, Yue-Yue Chang, Tong Wang, Wei Chen, Gao-Yan Tong, Ru-Qin Yu.  (2021)  Simultaneous determination of nine tyrosine kinase inhibitors in three complex biological matrices by using high-performance liquid chromatography–diode array detection combined with a second-order calibration method.  JOURNAL OF SEPARATION SCIENCE,  44  (21): (3914-3923).  [PMID:34463059] [10.1002/jssc.202100293]

6. Deng-Pan Wu, Yan Zhou, Li-Xiang Hou, Xiao-Xiao Zhu, Wen Yi, Si-Man Yang, Tian-Yu Lin, Jin-Lan Huang, Bei Zhang, Xiao-Xing Yin.  (2021)  Cx43 deficiency confers EMT-mediated tamoxifen resistance to breast cancer via c-Src/PI3K/Akt pathway.  International Journal of Biological Sciences,      [PMID:34326682] [10.7150/ijbs.55453]

7. Dawei Yang, Xiaoyu Tian, Yuchen Ye, Yin Liang, Jie Zhao, Tao Wu, Na Lu.  (2021)  Identification of GL-V9 as a novel senolytic agent against senescent breast cancer cells.  LIFE SCIENCES,      [PMID:33617857] [10.1016/j.lfs.2021.119196]

8. Qingqing Li, Xianwei Yang, Peipei Zhang, Fei Mo, Peiru Si, Ximeng Kang, Menghan Wang, Jiye Zhang.  (2021)  Dasatinib loaded nanostructured lipid carriers for effective treatment of corneal neovascularization.  Biomaterials Science,  9  (7): (2571-2583).  [PMID:33589891] [10.1039/D0BM01599G]

9. Yue-Yue Chang, Hai-Long Wu, Huan Fang, Tong Wang, Yang-Zi Ouyang, Xiao-Dong Sun, Gao-Yan Tong, Yu-Jie Ding, Ru-Qin Yu.  (2020)  Comparison of three chemometric methods for processing HPLC-DAD data with time shifts: Simultaneous determination of ten molecular targeted anti-tumor drugs in different biological samples.  TALANTA,      [PMID:33379025] [10.1016/j.talanta.2020.121798]

10. Qianqian Wang, Yuanyuan Zheng, Bowen Deng, Di Chen, Liuqun Jia, Nian Shi.  (2024)  Automated kapok fiber-based pipette-tip solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry for rapid and sensitive analysis of tyrosine kinase inhibitors in plasma.  JOURNAL OF CHROMATOGRAPHY A,      [PMID:39378625] [10.1016/j.chroma.2024.465420]

11. Lisha Liu, Beiyuan Zhang, Xianggui Wu, Gang Cheng, Xiaopeng Han, Xiaofei Xin, Chao Qin, Lei Yang, Meirong Huo, Lifang Yin.  (2024)  Bioresponsive nanocomplex integrating cancer-associated fibroblast deactivation and immunogenic chemotherapy for rebuilding immune-excluded tumors.  Nanomedicine-Nanotechnology Biology and Medicine,      [PMID:38484918] [10.1016/j.nano.2024.102743]

12. Xiaolan Zhou, Xiaofeng Zhu, Weixu Wang, Jing Wang, Haimei Wen, Yuqi Zhao, Jiayu Zhang, Qiushi Xu, Zhaozhao Zhao, Ting Ni.  (2025)  Comprehensive Cellular Senescence Evaluation to Aid Targeted Therapies.  Research,      [PMID:39822281] [10.34133/research.0576]

13. Jiaxing Lei, Lei Wang, Chen Yang, Dongdong Li, Jiaxue Zhang, Jia Ma, Peipei Zhang, Qingqing Li, Jiye Zhang.  (2024)  Dasatinib and erianin co-loaded ion-responsive in-situ hydrogel for effective treatment of corneal neovascularization.  JOURNAL OF CONTROLLED RELEASE,      [PMID:39368709] [10.1016/j.jconrel.2024.10.001]

14. Jing Ye, Yuanyuan Zheng, Xiangyu Li, Xingyi Jiang, Di Chen.  (2024)  Melt-blown polypropylene nonwoven as an efficient and eco-economic sorbent for pipette tip micro-solid phase extraction for the determination of tyrosine kinase inhibitors.  ANALYTICA CHIMICA ACTA,      [PMID:39396303] [10.1016/j.aca.2024.343240]

15. Qianqian Wang, Yuwei Liu, Yuanyuan Zheng, Di Chen, Ya Xie, Nian Shi.  (2024)  MonoTip C18 pipette tip solid-phase extraction coupled with liquid chromatography-tandem mass spectrometry enables rapid and automated therapeutic drug monitoring of tyrosine kinase inhibitors.  Arabian Journal of Chemistry,      [PMID:] [10.1016/j.arabjc.2024.105976]

16. Ninghong Li, Lu Liu, Dong Liu, Hengyi Yu, Guangjie Yang, Lihui Qiu, Yufei Chen, Dong Xiang, Xuepeng Gong.  (2024)  Simultaneous determination of three tyrosine kinase inhibitors and three triazoles in human plasma by LC-MS/MS: applications to therapeutic drug monitoring and drug-drug interaction studies.  JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES,      [PMID:39208604] [10.1016/j.jchromb.2024.124276]

17. Haolin Song, Hongyi Chen, Qinjun Chen, Hongrui Fan, Chufeng Li, Yu Wang, Shilin Zhang, Xuwen Li, Boyu Su, Tao Sun, Chen Jiang.  (2024)  Size and Charge Dual-Switchable Nanoparticles for Achieving Chemosensitization and Immune Infiltration against Pancreatic Ductal Adenocarcinoma.  ADVANCED FUNCTIONAL MATERIALS,      [PMID:] [10.1002/adfm.202411643]

18. Dong Wang, Mengrong Li, Tingting Dai, Xiangyu Zhang, Di Chen.  (2025)  Sensitive analysis of tyrosine kinase inhibitors in plasma using polypropylene fabric-solid phase extraction combined with liquid chromatography-tandem mass spectrometry.  JOURNAL OF CHROMATOGRAPHY A,      [PMID:40865307] [10.1016/j.chroma.2025.466315]

19. Gankun Yuan, Ruyue Yang, Wenjing Wen, Zhaoyi Wei, Meiru Song, Lingyang Zhang, Kun Hou, Gaofeng Liang.  (2025)  Endoplasmic Reticulum-Targeted Photodynamic Therapy Combined with Autophagy Inhibition to Enhance Synergistic Immunotherapy for Triple-Negative Breast Cancer.  CHEMISTRY-A EUROPEAN JOURNAL,      [PMID:40350379] [10.1002/chem.202500146]

20. Mengnan Yang, Yuqing Tong, Shaoping Yin, Hengchuan Zhang, Xiaowen Huang, Kai Yuan, Yanfei Hao, Jianping Zhou, Meirong Huo, Tingjie Yin.  (2025)  Microthrombi targeted nano-micelle synchronizing endothelial gap opening and matrix decompression for augmenting drug perfusion within pancreatic cancer.  Acta Pharmaceutica Sinica B,      [PMID:] [10.1016/j.apsb.2025.12.037]

21. Wang Dong, Li Mengrong, Zhang Xiangyu, Chai Shiwei, Chen Di.  (2026)  Ultrasonic-assisted magnetic sorbent–wrapped stick dip extraction enables batch-scale and green LC-MS/MS analysis of tyrosine kinase inhibitors in plasma.  ANALYTICAL AND BIOANALYTICAL CHEMISTRY,      [PMID:41575510] [10.1007/s00216-026-06335-2]

22. Gao Hengyuan, Lin Junqing, Chen Xiaobing, Su Yingshi, Huang Yibin, Zhang Yubo, Zhang Junchang, Xu Nan, Dai Xiaoyong.  (2026)  Microfluidic-based patient-derived organoids recapitulate thyroid cancer heterogeneity and reveal NF-κB-driven maturation for precision therapy.  Journal of Translational Medicine,      [PMID:41761289] [10.1186/s12967-026-07882-z]

23. Jiansong Zhao, Tian Yin, Yaxin Deng, Hongbing Liu, Mingli Wei, Chenxiao Chu, Xinxin Liang, Xiaoshuang Bi, Haibing He, Jingxin Gou, Xing Tang, Yu Zhang.  (2026)  Harnessing semen-derived exosomes for noninvasive fundus drug delivery: A paradigm for exosome-based ocular fundus therapeutics.  Science Advances,  12  (13):   [PMID:] [10.1126/sciadv.adw7275]